CRYSTAL WATKINS: Open Payments
NPI 1790272607 · LOGAN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,085 in 114 payments from 16 companies in 2025. Trend: 2023 $1,094 · 2024 $2,109 · 2025 $2,085
Food & beverage: $2,008Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $590 |
| PFIZER INC. | 10 | $216 |
| ABBVIE INC. | 17 | $216 |
| Gilead Sciences, Inc. | 12 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $162 |
| Celltrion USA Inc. | 15 | $157 |
| GENZYME CORPORATION | 6 | $110 |
| Ipsen Biopharmaceuticals, Inc | 5 | $109 |
| Madrigal Pharmaceuticals | 1 | $91 |
| Aimmune Therapeutics, Inc. | 2 | $56 |
Products named: TREMFYA, ENTYVIO, VEGZELMA, RINVOQ, XELJANZ, DUPIXENT, IQIRVO, REZDIFFRA.
Industry payments across WV — which companies pay providers there.
